Shenzhen Hepalink Pharmaceutical Group Balance Sheet Health
Financial Health criteria checks 5/6
Shenzhen Hepalink Pharmaceutical Group has a total shareholder equity of CN¥12.1B and total debt of CN¥4.9B, which brings its debt-to-equity ratio to 40%. Its total assets and total liabilities are CN¥18.9B and CN¥6.7B respectively.
Key information
40.0%
Debt to equity ratio
CN¥4.86b
Debt
| Interest coverage ratio | n/a |
| Cash | CN¥2.50b |
| Equity | CN¥12.14b |
| Total liabilities | CN¥6.74b |
| Total assets | CN¥18.87b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 002399's short term assets (CN¥10.4B) exceed its short term liabilities (CN¥4.6B).
Long Term Liabilities: 002399's short term assets (CN¥10.4B) exceed its long term liabilities (CN¥2.1B).
Debt to Equity History and Analysis
Debt Level: 002399's net debt to equity ratio (19.4%) is considered satisfactory.
Reducing Debt: 002399's debt to equity ratio has reduced from 62.4% to 40% over the past 5 years.
Debt Coverage: 002399's debt is well covered by operating cash flow (30.7%).
Interest Coverage: Insufficient data to determine if 002399's interest payments on its debt are well covered by EBIT.